A. Sinclair Dunlop - 01 Jun 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Other	$0	-31,855	-100%	$0.000000^*	0	01 Jun 2021	See Footnote	F1, F2
transaction	APLS	Common Stock	Other	$0	+13,108	+22%	$0.000000	73,108	01 Jun 2021	Direct	F1
transaction	APLS	Common Stock	Other	$0	+2,682	+0.89%	$0.000000	303,361	01 Jun 2021	See Footnote	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Distributions from MASA Life Science Ventures, LP ("MASA"), of which the reporting person is a managing partner. Of the 31,855 shares distributed by MASA, 13,108 were distributed to the reporting person and 2,682 were distributed to Epidarex Capital I, LP ("Epidarex").
F2	The securities are held by MASA and the reporting person, a managing partner of MASA, may be deemed to have voting and dispositive power over the shares held by MASA. The reporting person disclaims beneficial ownership over the shares held by MASA except to the extent of his pecuniary interest therein.
F3	The securities are held by Epidarex and the reporting person, a general partner of Epidarex, may be deemed to have voting and dispositive power over the shares held by Epidarex. The reporting person disclaims beneficial ownership over the shares held by Epidarex except to the extent of his pecuniary interest therein.